SCHEMBL21058652

SCHEMBL21058652

FC(F)(F)Oc1ccc(-c2cc(Cl)nc(Cl)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.49
CHRNA7 P36544 4/20 0.46
ACP1 P24666 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ALOX5 P09917 1/20 0.45
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
SCN5A Q14524 4/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 1/20 0.42
SCN10A Q9Y5Y9 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22712349 0.81 DHODH (0.44) DHODHCHRNA7ACP1ADORA3ALOX5
SCHEMBL10051515 0.80 MEN1 (0.60) MAPTL3MBTL1KDM4EALDH1A1MEN1
SCHEMBL21001335 0.80 KMO (0.58) DHODHCHRNA7ACP1ADORA3SCN10A
SCHEMBL3997703 0.80 AKR1C2 (0.50) DHODHCHRNA7ALOX5MAPTL3MBTL1
SCHEMBL29020178 0.79 DHODH (0.57) DHODHCHRNA7ACP1ADORA3SCN10A
Potassium SCHEMBL29961825 0.79 DHODH (0.57) DHODHCHRNA7ACP1ADORA3SCN10A
SCHEMBL4619849 0.78 ALDH1A1 (0.46) ADORA3ALOX5MAPTL3MBTL1RECQL
SCHEMBL3451541 0.78 KDM4E (0.67) MAPTL3MBTL1MAPK1KDM4EALDH1A1
Potassium Ion SCHEMBL29020198 0.78 DHODH (0.50) DHODHCHRNA7ACP1ADORA3SCN10A
SCHEMBL1229053 0.77 ABL1 (0.52) DHODHALOX5MAPTL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185456-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2019-06-20 US disclosed
CN-107759571-A Inhibitors of influenza viruses replication and its application method and purposes 广东东阳光药业有限公司 2018-03-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185456-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF POLRMT, EIF2AK2, POLM DHODH 1097/4885CHRNA7 4531/4885ACP1 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.